Make your appointment with the doctor to get an insider’s look at three of the most interesting stocks in biotech/healthcare each month.
About our speaker Dr. Mark Charest:
Mark Charest, PhD, holds eight patents and an FDA drug approval to his name, not to mention his stellar investment track record as the Portfolio Manager for the AlphaCentric LifeSci Healthcare Fund.
- 12+ year career as an investor at several specialized $1B+ AUM healthcare funds
- Led Medicinal Chemistry Lab at the Novartis Institutes for BioMedical Research focused on Oncology drug discovery
- Co-inventor on 8 drug patents, including FDA-approved therapeutic
- Kauffman Fellow, National Science Foundation Graduate Research Fellow
- Ph.D. and M.S. in Chemistry and Chemical Biology from Harvard University